EP2663561
Nýjar heterósýklískar afleiður og notkun þeirra við að meðhöndla taugaraskanir
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
11.1.2012EP published:
16.3.2016EP application number:
12700390.3
EP translation filed:
23.5.2016Grant published:
15.6.2016EPO information:
European Patent Register
Max expiry date:
10.1.2032Expiry date:
10.1.2020
Title:
NOVEL HETEROCYCLIC DERIVATIVES AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS
Timeline
Today
11.1.2012EP application
16.3.2016EP Publication
23.5.2016Translation submitted
15.6.2016Registration published
10.1.2020Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
BADIGER, SangameshAddress:
Karnataka 560 100, IN
Name:
CHEBROLU, MuraliAddress:
Karnataka 560 100, IN
Name:
HURTH, KonstanzeAddress:
Basel, CH
Name:
JACQUIER, SébastienAddress:
Basel, CH
Name:
LUEOEND, Rainer MartinAddress:
Basel, CH
Name:
MACHAUER, RainerAddress:
Basel, CH
Name:
RUEEGER, HeinrichAddress:
Basel, CH
Name:
TINTELNOT-BLOMLEY, MarinaAddress:
Basel, CH
Name:
VEENSTRA, Siem JacobAddress:
Basel, CH
Name:
VOEGTLE, MarkusAddress:
Basel, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
DE00772011Date:
13.1.2011Country:
IN
Number:
201161534591 PDate:
14.9.2011Country:
US
Classification
Categories:
C07D 413/14, C07D 471/04, C07D 487/04, A61K 31/5377, A61P 25/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 28.12.2016
Expires: 10.1.2018
Payer: Árnason Faktor
Number: 7
Paid: 29.12.2017
Expires: 10.1.2019
Payer: Árnason Faktor
Number: 8
Paid: 2.1.2019
Expires: 10.1.2020
Payer: Árnason Faktor